Treatment | Day of treatment or re-infestation1 | |||||||
---|---|---|---|---|---|---|---|---|
0 | 14 | 29 | 44 | 59 | 74 | 90 | ||
Placebo | Range | 39–90 | 54–74 | 30–91 | 45–87 | 37–81 | 45–82 | 21–71 |
A. mean | 68.0 | 65.3 | 63.8 | 65.6 | 66.9 | 64.1 | 50.5 | |
G. mean2 | 66.1a | 64.9a | 60.2a | 63.5a | 65.2a | 63.0a | 47.4a | |
Sarolaner | Range | 0–0 | 0–0 | 0–0 | 0–0 | 0–0 | 0–0 | 0–0 |
A. mean | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Efficacy (%) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
G. mean2 | 0.0b | 0.0b | 0.0b | 0.0b | 0.0b | 0.0b | 0.0b | |
Efficacy (%) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
P-value vs. placebo | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
Fluralaner | Range | 0–0 | 0–0 | 0–0 | 0–0 | 0–1 | 0–17 | 0–15 |
A. mean | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 2.5 | 2.3 | |
Efficacy (%) | 100 | 100 | 100 | 100 | 99.8 | 96.1 | 95.5 | |
G. mean2 | 0.0b | 0.0b | 0.0b | 0.0b | 0.1b | 0.7b | 0.8b | |
Efficacy (%) | 100 | 100 | 100 | 100 | 99.9 | 98.9 | 98.4 | |
P-value vs. placebo | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
P-value vs. sarolaner | 1.000 | 1.000 | 1.000 | 1.0000 | 0.4040 | 0.1128 | 0.0630 |